Therapy resistance in AML is mediated by cytoplasmic sequestration of the transcriptional repressor IRF2BP2
Mark J. Althoff(University of Colorado Anschutz Medical Campus), Craig T. Jordan(University of Colorado Anschutz Medical Campus)
Cited by 0
Related Papers
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
|Blood|2005|675
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
|Cancer Cell|2018|565
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
|Cancer Discovery|2020|550